Clinical Trial

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Study acronym: IRIS-DES
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Trial Details
NCT Number NCT01186133
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions Coronary Artery Disease, Percutaneous Transluminal Coronary Angioplasty
Enrollment 50,000 participants
Start Date 2009-01
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-30